TABLE 1.
Total (n = 1411) | |||
---|---|---|---|
Characteristics | No. (%) | Characteristics | No. (%) |
Age(years), mean (SD) [range] | 72.6 (12.2) [25–100] | Comorbidity | |
Male sex | 716 (50.7) | Cardiovascular | 82 (5.8) |
Primary cancer site | Cerebrovascular | 112 (7.9) | |
Lung | 242 (17.1) | Lung | 83 (5.8) |
Stomach/Esophagus | 207 (14.67) | Diabetes mellitus | 184 (13.0) |
Colon/Rectum | 186 (13.1) | Dementia | 125 (8.8) |
Prostate/Bladder/Kidney/Testis | 102 (7.2) | Eastern cooperative oncology group performance status | |
Pancreas | 146 (10.3) | ||
Ovary/Uterus | 82 (5.8) | 0–1 | 8 (0.6) |
Liver/Biliary system | 121 (8.5) | 2 | 79 (5.6) |
Others | 325 (23.0) | 3 | 549 (38.9) |
Metastatic site | 4 | 775 (54.9) | |
Liver | 565 (40.0) | Palliative Performance Scale | |
Bone | 380 (26.9) | 20 or less | 326 (23,1) |
Lung | 530 (37.5) | 30 | 296 (21.0) |
Cancer treatment | 40 | 410 (29.0) | |
Surgery | 594 (42.0) | 50 | 281 (20.0) |
Chemotherapy | 866 (61.3) | 60 and above | 98 (6.9) |
Hormonal therapy | 14 (0.9) | ||
Radiation therapy | 11 (0.7) | Prediction of prognosis (days), mean(SD) [range] | 27.1 (22.9) [0–180] |
Abbreviation: SD, standard deviation.